Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes
about
Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donorConstruction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity.Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizingCombinatorial approach to hepadnavirus-like particle vaccine designA modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hostsBacterial superglue enables easy development of efficient virus-like particle based vaccines.Rabies virus nucleoprotein as a carrier for foreign antigens.NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine.P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.Advantages to the use of rodent hepadnavirus core proteins as vaccine platformsEvaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particlesCombination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.Virus-like particles: flexible platforms for vaccine development.Molecular epidemiology of Plasmodium vivax in Latin America: polymorphism and evolutionary relationships of the circumsporozoite geneNative display of complete foreign protein domains on the surface of hepatitis B virus capsids.Use of hepadnavirus core proteins as vaccine platforms.Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.Virus-like particles in vaccine development.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Hepatitis B core-based virus-like particles to present heterologous epitopes.Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice.Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunitAttenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.Inhibition of IGF receptor signaling and hepatoma cell growth by an antibody to ligand oligopeptide of receptor.Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trialThe hepatitis nucleocapsid as a vaccine carrier moiety.MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide.HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein.
P2860
Q24798369-7F09E216-1F0B-40E9-AB56-22791109799EQ33231853-DFF37740-2A20-439C-98A9-A5D915A88EF7Q33318466-445A3CF5-142B-400E-AFF3-0E630079B41BQ33967341-1AD0B7AB-6B7B-437B-A2D0-BC81A70AB554Q34092773-7066F052-A9B8-4718-803E-1B8005AEBBCAQ34261339-7E30C726-E877-4796-8B98-A3D0E0729DADQ34523734-4E58A5E6-D756-497F-B5BC-253161B6B470Q35320069-45B77DEC-CC60-426A-BCBB-52325707CDBDQ35519418-AC15B315-2FB0-46B6-8BAD-57982E8787FAQ35541210-F3782DA7-3C8D-4E31-B889-64942FD495DBQ35561160-E9B2473E-0721-4926-BA85-EB9A0E9839B7Q35663329-D2513A13-A9D5-415B-8A32-C5F261EB7186Q36076230-425F62E0-863D-421A-AA17-BA56CA81682EQ36262265-41DE2CCD-174D-4908-A3F0-BA8F77747C85Q36313990-FBB42EE0-F20F-4665-A257-AC930F948610Q36383811-06D2DC38-30BB-44D8-8969-98CE36A5A3D3Q36726849-51EC8F02-6D03-4A59-8E17-0DEFB1197298Q36837144-9DC7ABFD-DBBD-4B90-84F2-EEC3F59F07D0Q37060119-45C00A1E-ADA4-4B62-A353-A35A8409D8FBQ37163704-51B09B05-6A72-4B42-A578-73894672F1B2Q37622906-83D977BA-92B7-47D3-8893-A6A21BE26DC0Q37634520-06D089B0-2554-45A6-AA0B-F07CAA57BB10Q37798008-1A0C473C-04DC-433E-85E4-8A0A35537B75Q37951525-4D062704-EF75-4F23-A411-409DE1E97637Q38081969-A2AA8A58-A5F2-4EE6-893D-0C0847BCBDE4Q38156841-DE357C78-BC2B-4593-98CE-51974069A4BEQ38606892-7305F27A-1B6C-48D0-89E7-79608AB3A8F3Q39824887-9B5D5F33-A78B-4243-B4AA-160093B901A8Q39998569-975C35E5-E188-4A85-9DFE-BE53B1DD487DQ40205403-8B494FF4-F324-4A8D-B33D-7733442F3121Q42754531-138866A8-A087-41A7-84A9-4B50E5768775Q46627645-321026DF-A45A-4ED8-BFCB-EF5A9C670105Q48002979-21BA296A-8954-4C6C-823C-493E2662B7C4Q52979262-1BE46DD5-240E-4E7A-9829-14237217C2F8
P2860
Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Immunity to malaria elicited b ...... cumsporozoite protein epitopes
@ast
Immunity to malaria elicited b ...... cumsporozoite protein epitopes
@en
type
label
Immunity to malaria elicited b ...... cumsporozoite protein epitopes
@ast
Immunity to malaria elicited b ...... cumsporozoite protein epitopes
@en
prefLabel
Immunity to malaria elicited b ...... cumsporozoite protein epitopes
@ast
Immunity to malaria elicited b ...... cumsporozoite protein epitopes
@en
P2093
P2860
P356
P1476
Immunity to malaria elicited b ...... cumsporozoite protein epitopes
@en
P2093
D Peterson
P2860
P304
P356
10.1084/JEM.180.3.1037
P407
P577
1994-09-01T00:00:00Z